WinRho® SDF (Rho(D) Immune Globulin) is licensed to treat immune thrombocytopenic purpura (ITP) and to prevent hemolytic disease of the newborn (HDN). WinRho® SDF is sold in over 40 countries worldwide.
HepaGam B™ [Hepatitis B Immune Globulin Intravenous (Human)] is the first HBIG licensed by the FDA for the prevention of Hepatitis B recurrence following liver transplantation in HBsAg-positive liver transplant patients. HepaGam B is also FDA licensed for treatment of acute exposure to hepatitis B infection.
HepaGam B™ is also licensed in Canada for the prevention of Hepatitis B recurrence following liver transplantation in adult patients with Hepatitis B as found under Health Canada's Notice of Compliance with Conditions (NOC/c) policy.
VariZIG™ (Varicella Zoster Immune Globulin) is a licensed, highly purified and specialized antibody preparation against the virus that causes chickenpox.
Vaccinia Immune Globulin (VIG) is Cangene's first biodefense product licensed by the US Food & Drug Administration. VIG contains specific antibodies to the vaccinia virus (the virus used to make smallpox vaccine) and is licensed to treat certain complications associated with smallpox vaccination to the smallpox vaccine.
Anthrax Immune Globulin (AIG) is an investigational product derived from plasma obtained from donors immunized with the Anthrax vaccine.
Botulism Antitoxin Botulism Antitoxin (BAT) is an investigational product containing neutralizing antibodies to the seven botulinum toxin types: A, B, C, D, E, F, and G.
Leucotropin™ (GM-CSF) is a protein that stimulates the production of infection-fighting white blood cells in the body depleted by chemotherapy and radiation.
Accretropin™ (hGH) Cangene's Human Growth
Hormone is a recombinant protein which promotes the growth
of long bones of the body until the onset of puberty. Accretropin™ has been licensed by the FDA.
|
